{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:08:56Z","timestamp":1789524536406,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.purol.2013.10.015","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T10:30:46Z","timestamp":1386239446000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Int\u00e9r\u00eat de la densit\u00e9 du PSA comme facteur pr\u00e9dictif chez les patients afro-carib\u00e9ens \u00e9ligibles \u00e0 la surveillance active du cancer de prostate selon les crit\u00e8res du protocole fran\u00e7ais"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"Loiselle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Senechal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nevoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Benazzouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bhakkan-Mambir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Casenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gourtaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fofana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.purol.2013.10.015_bib0005","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.eururo.2005.02.020","article-title":"Prostate cancer incidence in Guadeloupe, a French Caribbean archipelago","volume":"47","author":"Mallick","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2013.10.015_bib0010","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2004.10.062","article-title":"The changing face of low-risk prostate cancer: trends in clinical presentation and primary management","volume":"22","author":"Cooperberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.10.015_bib0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000480794","article-title":"Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis","volume":"32","author":"Gerber","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2013.10.015_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jama.1995.03530080042039","article-title":"Long-term survival among men with conservatively treated localized prostate cancer","volume":"274","author":"Albertsen","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.purol.2013.10.015_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/jama.1997.03540300035030","article-title":"Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden","volume":"277","author":"Johansson","year":"1997","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.purol.2013.10.015_bib0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.purol.2011.02.015","article-title":"Place de la surveillance active dans le cancer de la prostate \u00e0 faible risque de progression","volume":"21","author":"Staerman","year":"2011","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2013.10.015_bib0035","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0022-5347(05)65174-9","article-title":"Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and\/or clinical progression","volume":"167","author":"Choo","year":"2002","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2013.10.015_bib0040","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/S1761-676X(08)70021-X","article-title":"Active surveillance in prostate cancer: the French protocol","volume":"18","author":"Mottet","year":"2008","journal-title":"Prog Urol FMC"},{"issue":"5","key":"10.1016\/j.purol.2013.10.015_bib0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","article-title":"Pathologic and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer","volume":"271","author":"Epstein","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.purol.2013.10.015_bib0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.eururo.2012.11.005","article-title":"Active surveillance for low-risk prostate cancer worldwide: the PRIAS Study","volume":"63","author":"Bul","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2013.10.015_bib0055","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.juro.2010.01.001","article-title":"Risk stratification of men choosing surveillance for low risk prostate cancer","volume":"183","author":"Tseng","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.10.015_bib0060","doi-asserted-by":"crossref","first-page":"831e","DOI":"10.1016\/j.urology.2012.12.046","article-title":"Increased incidence of pathologically non-organ confined prostate cancer in African-American men eligible for active surveillance","volume":"81","author":"Ha","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.purol.2013.10.015_bib0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cncr.21954","article-title":"African-American men with non-palpable prostate cancer exhibit greater tumor volume than matched white men","volume":"107","author":"Sanchez-Ortiz","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2013.10.015_bib0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.purol.2013.10.015_bib0075","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2010.1720","article-title":"Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis","volume":"304","author":"Hayes","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.purol.2013.10.015_bib0080","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pros.21314","article-title":"Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer","volume":"71","author":"Chornokur","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.purol.2013.10.015_bib0085","unstructured":"InVS. Mortalit\u00e9 observ\u00e9e par cancer dans les DOM (Martinique, Guadeloupe, R\u00e9union, Guyane) entre 1984\u00a0et 2008."},{"key":"10.1016\/j.purol.2013.10.015_bib0090","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.juro.2010.01.015","article-title":"Evidence supports a faster growth rate and\/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity","volume":"183","author":"Powell","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2013.10.015_bib0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.urology.2012.04.051","article-title":"Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study","volume":"80","author":"Beauval","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.purol.2013.10.015_bib0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/pcan.2012.38","article-title":"Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center","volume":"16","author":"Abern","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.purol.2013.10.015_bib0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1148\/radiol.13121325","article-title":"Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?","volume":"268","author":"Turkbey","year":"2013","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.purol.2013.10.015_bib0110","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1464-410X.2012.11641.x","article-title":"Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance","volume":"111","author":"Mullins","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2013.10.015_bib0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0301-5629(94)00084-0","article-title":"Errors in transrectal ultrasonic planimetry of the prostate: computer simulation of volumetric errors applied to a screening population","volume":"21","author":"Bangma","year":"1995","journal-title":"Ultrasound Med Biol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713007860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708713007860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:24:25Z","timestamp":1761114265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708713007860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1166708713007860"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2013.10.015","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat de la densit\u00e9 du PSA comme facteur pr\u00e9dictif chez les patients afro-carib\u00e9ens \u00e9ligibles \u00e0 la surveillance active du cancer de prostate selon les crit\u00e8res du protocole fran\u00e7ais","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2013.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}